在使用医疗信息技术的模拟试验中,抗药物的比较有效性
Kevin Xie1,2, Jacob Korzun3, Daniel J Zhou2,3
1Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Brain : a journal of neurology
|July 15, 2025
概括
人工智能分析了电子健康记录,以比较抗发作药物 (ASM). 在一线治疗中, levetiracetam 和lamotrigine 显示出比oxcarbazepine 更好的发作自由度和留率.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 抗发作药物 (ASM) 通常是通过试错来处方的.
- 除了最初的ASM处方之外,还存在有限的比较有效性数据.
- 人工智能 (AI) 可以从电子健康记录 (EHR) 中提取有价值的数据.
研究的目的:
- 使用人工智能驱动的仿真临床试验进行ASM的比较有效性研究.
- 分析各种ASM的自由度和药物保留率.
- 为了利用现实世界的数据来改进治疗策略.
主要方法:
- 使用因果推断和信息学框架的回顾性队列研究.
- 自然语言处理 (NLP) 算法从EHR中提取了的共变量和发作结果.
- 权重卡普兰-梅尔分析和日志排名测试比较了ASM的自由 (2年) 和药物保留 (5年).
主要成果:
- 在第一线治疗中, levetiracetam 和lamotrigine 在发作自由和留方面优于oxcarbazepine.
- 对于二线治疗,lacosamide显示出优越的保留,而托皮拉则提供了更好的发作自由.
- 第三线研究结果表明有效性各不相同,锡诺巴酸比克洛巴和布里瓦拉塞坦具有更长的保留时间,但比克洛巴和布里瓦拉塞坦更低的发作自由度.
结论:
- 使用真实世界EHR数据的模拟临床试验为比较有效性研究提供了强大的框架.
- 在ASM中,发作自由和保留存在显著差异,为未来的治疗决策提供了信息.
- 研究结果为潜在的随机试验产生假设,以验证ASM的比较有效性.
更多相关视频
06:45Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
9.1K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.5K
相关概念视频
01:24Epilepsy and Seizures: Overview
285
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
285
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
455
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
455
01:20Antiepileptic Drugs: Potassium Channel Activators
282
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
282
01:17Antiepileptic Drugs: Calcium Channel Blockers
639
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
639
01:14Antiepileptic Drugs: Glutamate Antagonists
521
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
521
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
660
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
660